Citigroup Reiterates Neutral on Healthpeak Properties, Maintains $22 Price Target
Portfolio Pulse from richadhand@benzinga.com
Citigroup analyst Michael Griffin reiterated a Neutral rating on Healthpeak Properties (NYSE:PEAK) and maintained a $22 price target.

June 15, 2023 | 1:19 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Citigroup analyst Michael Griffin reiterated a Neutral rating on Healthpeak Properties and maintained a $22 price target.
The news is directly related to Healthpeak Properties as Citigroup analyst Michael Griffin reiterated a Neutral rating and maintained a $22 price target. This indicates that the analyst does not expect significant price movement in the short term, hence the neutral score. The relevance, importance, and confidence are high as the rating comes from a reputable financial institution and directly impacts the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100